Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma? Ronald M. Bukowski Clinical Trial Report 03 February 2010 Pages: 77 - 79
RANK Ligand: Effects of Inhibition Saby GeorgeAndrew BrennerRonald M. Bukowski ReviewPaper 03 March 2010 Pages: 80 - 86
Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer James M. ClearyGeoffrey I. Shapiro ReviewPaper 09 March 2010 Pages: 87 - 94
Hsp90: A Drug Target? Jeffrey M. HolzbeierleinAndrew WindspergerGeorge Vielhauer OriginalPaper 13 February 2010 Pages: 95 - 101
Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors Susan A. J. VaziriJenny KimRam Ganapathi OriginalPaper 23 February 2010 Pages: 102 - 108
Quality Initiatives in Head and Neck Cancer Amy Y. Chen OriginalPaper 06 February 2010 Pages: 109 - 114
Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer David J. AdelsteinCristina P. Rodriguez OriginalPaper 04 February 2010 Pages: 115 - 120
Nanotechnology in Head and Neck Cancer: The Race Is On Ivan H. El-Sayed ReviewPaper Open access 03 March 2010 Pages: 121 - 128
Oral Cavity Squamous Cell Carcinoma and the Clinically N0 Neck: The Past, Present, and Future of Sentinel Lymph Node Biopsy Andrew CoughlinVicente A. Resto ReviewPaper 02 March 2010 Pages: 129 - 135
The Relationship Between Vitamin D and Breast Cancer Incidence and Natural History Qamar J. KhanBruce F. KimlerCarol J. Fabian OriginalPaper 17 February 2010 Pages: 136 - 142